{"filing":{"accession_number":"0001683168-26-005458","cik":"0001402328","ticker":"SBFMW","company_name":"Sunshine Biopharma Inc.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"sunshine_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/sunshine_8k.htm"},"events":[{"id":17389,"run_id":15566,"accession_number":"0001683168-26-005458","anchor_item_number":"1.01","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.75,"summary":"The filing discloses entry into a Release Agreement settling a dispute with the former president of a wholly-owned subsidiary, with the Company agreeing to pay CAD$1,500,000 (approximately US$1.06 million). While Item 1.01 typically covers M\u0026A activity, this is a settlement agreement resolving a dispute rather than an acquisition, merger, or change of control. The event is material due to the significant cash outlay and resolution of a dispute with a former executive, but it is fundamentally a legal settlement rather than a transaction in the M\u0026A sense, making legal_other the most appropriate classification.","company_name":"Sunshine Biopharma Inc.","ticker":"SBFMW","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":[{"id":15834,"accession_number":"0001683168-26-005458","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.75,"reasoning":"The filing discloses entry into a Release Agreement settling a dispute with the former president of a wholly-owned subsidiary, with the Company agreeing to pay CAD$1,500,000 (approximately US$1.06 million). While Item 1.01 typically covers M\u0026A activity, this is a settlement agreement resolving a dispute rather than an acquisition, merger, or change of control. The event is material due to the significant cash outlay and resolution of a dispute with a former executive, but it is fundamentally a legal settlement rather than a transaction in the M\u0026A sense, making legal_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-11T00:11:51.131209+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15834,"accession_number":"0001683168-26-005458","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.75,"reasoning":"The filing discloses entry into a Release Agreement settling a dispute with the former president of a wholly-owned subsidiary, with the Company agreeing to pay CAD$1,500,000 (approximately US$1.06 million). While Item 1.01 typically covers M\u0026A activity, this is a settlement agreement resolving a dispute rather than an acquisition, merger, or change of control. The event is material due to the significant cash outlay and resolution of a dispute with a former executive, but it is fundamentally a legal settlement rather than a transaction in the M\u0026A sense, making legal_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-11T00:11:51.131209+00:00","company_name":"Sunshine Biopharma Inc.","ticker":"SBFMW","filing_date":"2026-07-10"}]}